MERCURY PHARMACEUTICALS LIMITED

02619880
Active London

Manufacture of basic pharmaceutical products

2 employees website.com
Life sciences and medical technology Manufacture of basic pharmaceutical products
M

MERCURY PHARMACEUTICALS LIMITED

02619880

Manufacture of basic pharmaceutical products

Founded 12 Jun 1991 Active London, United Kingdom 2 employees website.com
Life sciences and medical technology Manufacture of basic pharmaceutical products

Previous Company Names

MERCURY PHARMA LIMITED 20 Mar 2012 — 26 Mar 2012
GOLDSHIELD PHARMACEUTICALS LTD. 2 Oct 1992 — 20 Mar 2012
CHECKEURO LIMITED 12 Jun 1991 — 2 Oct 1992
Accounts Submitted 7 Oct 2025 Next due 30 Sept 2026 3 months remaining
Confirmation Submitted 21 Jul 2025 Next due 21 Jul 2026 26 days remaining
Net assets £28M £3M 2024 year on year
Total assets £56M £2M 2024 year on year
Total Liabilities £28M £5M 2024 year on year
Charges 15
2 outstanding 13 satisfied

Contact & Details

Contact

Registered Address

Dashwood House 69 Old Broad Street London EC2M 1QS United Kingdom

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for MERCURY PHARMACEUTICALS LIMITED (02619880), an active life sciences and medical technology company based in London, United Kingdom. Incorporated 12 Jun 1991. Manufacture of basic pharmaceutical products. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type full
Next accounts 31 Dec 2025
Due by 30 Sept 2026 3 months remaining

Balance Sheet & P&L (2014–2024)

Cash in Bank

£862.00k

Decreased by £6.32M (-88%)

Net Assets

£27.57M

Increased by £3.02M (+12%)

Total Liabilities

£28.19M

Decreased by £5.13M (-15%)

Turnover

£98.14M

Increased by £14.84M (+18%)

Employees

2

Decreased by 2 (-50%)

Debt Ratio

51%

Decreased by 7 (-12%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Dec Year End
2023
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (1)

Mercury Pharma Group Limited
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active 2 Ceased
Active
Notified 1 Jun 2021
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Mercury Pharma Group Limited

Ceased 27 Mar 2020

Ceased

The Blackstone Group Inc.

Ceased 1 Jun 2021

Ceased

Group Structure

Group Structure

MERCURY PHARMACEUTICALS LIMITED Current Company

Charges

Charges

2 outstanding 13 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
7 Oct 2025AccountsAnnual accounts made up to 31 Dec 2024
21 Jul 2025Confirmation StatementConfirmation statement made on 7 Jul 2025 with no updates
20 Feb 2025OfficersAppointment of Mr. Melvin Jeremy Ferry as director on 6 Feb 2025
19 Feb 2025OfficersTermination of Vikram Laxman Kamath as director on 6 Feb 2025
2 Sept 2024AccountsAnnual accounts made up to 31 Dec 2023
7 Oct 2025 Accounts

Annual accounts made up to 31 Dec 2024

21 Jul 2025 Confirmation Statement

Confirmation statement made on 7 Jul 2025 with no updates

20 Feb 2025 Officers

Appointment of Mr. Melvin Jeremy Ferry as director on 6 Feb 2025

19 Feb 2025 Officers

Termination of Vikram Laxman Kamath as director on 6 Feb 2025

2 Sept 2024 Accounts

Annual accounts made up to 31 Dec 2023

Recent Activity

Latest Activity

Annual accounts made up to 31 Dec 2024

8 months ago on 7 Oct 2025

Confirmation statement made on 7 Jul 2025 with no updates

11 months ago on 21 Jul 2025

Appointment of Mr. Melvin Jeremy Ferry as director on 6 Feb 2025

1 years ago on 20 Feb 2025

Termination of Vikram Laxman Kamath as director on 6 Feb 2025

1 years ago on 19 Feb 2025

Annual accounts made up to 31 Dec 2023

1 years ago on 2 Sept 2024